Jeffrey Lawrence Schwartz insider trades: Kestra Medical Technologies (KMTS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
and 4 more companies
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | KMTS | ↓ Sell | 3,890 | $25.18 | $98K | Direct | Sep 10, 2026 (2d) |
| Mar 16, 2023 | SWTX | ↓ Sell | 1,750,000 | $28.50 | $49.9M | Indirect | Mar 20, 2023 (4d) |
| Aug 10, 2021 | SWTX | ↓ Sell | 1,000,000 | $70.25 | $70.3M | Indirect | Aug 12, 2021 (2d) |
| Jul 19, 2021 | RPID | ↑ Buy | 100,000 | $20.00 | $2.0M | Indirect | Jul 21, 2021 (2d) |
| Mar 9, 2021 | SWTX | ↓ Sell | 1,450,000 | $71.50 | $103.7M | Indirect | Mar 11, 2021 (2d) |
| Oct 26, 2020 | APTX | ↑ Buy | 3,333,333 | $3.00 | $10.0M | Indirect | Oct 27, 2020 (1d) |
| Jul 28, 2020 | ANNX | ↑ Buy | 400,000 | $17.00 | $6.8M | Indirect | Jul 28, 2020 (0d) |
| Feb 4, 2020 | ARQT | ↑ Buy | 294,117 | $17.00 | $5.0M | Indirect | Feb 6, 2020 (2d) |
| Nov 19, 2019 | DRNA | ↓ Sell | 1,750,000 | $22.03 | $38.6M | Indirect | Nov 21, 2019 (2d) |
| Sep 17, 2019 | SWTX | ↑ Buy | 150,000 | $18.00 | $2.7M | Indirect | Sep 19, 2019 (2d) |
| May 29, 2019 | DRNA | ↓ Sell | 1,600,000 | $12.50 | $20.0M | Indirect | May 31, 2019 (2d) |
| Jul 24, 2018 | REPL | ↑ Buy | 500,000 | $15.00 | $7.5M | Indirect | Jul 26, 2018 (2d) |
| Dec 19, 2017 | MRNS | ↓ Sell | 1,272,547 | $7.88 | $10.0M | Indirect | Dec 19, 2017 (0d) |
| Dec 18, 2017 | DRNA | ↑ Buy | 285,000 | $7.00 | $2.0M | Indirect | Dec 19, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KMTS insiders
Open-market trades in the last 12 months
About Jeffrey Lawrence Schwartz's insider trades
Jeffrey Lawrence Schwartz is an insider at Kestra Medical Technologies (KMTS). Since Dec 18, 2017, Jeffrey has reported 7 open-market purchases worth $36.0M and 7 sales worth $292.5M on SEC Form 4. In the last 12 months: 1 sale ($98K).
Their filings also include grants and awards (13 filings), conversions (5 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KMTS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.